or liquid chromatography / mass spectrometry (LC/MS). Over the past decade, many improvements to GC/MS and to LC/MS instrumentation have been made. This technology is one of the major analytical methods used to detect, identify and characterize toxic compounds such as fatty acid ethyl esters, glucides, proteins and other biomarkers of biological interest [5] [6] [7] [8] [9] [10] .
MS combined with HPLC or GC, are used to detect different compounds in meconium or in other biological products, during pregnancy or immediately after the act of birth. The results are very useful to understand the risks for the child and for the mother. Also, in case of any diseases or any health problem, a very early medical treatment can be chosen.
The biggest disadvantage of the method is that when meconium is used as biomarker, the obtained values will show the exposure to ethanol or to any other toxic compound, starting only from the fourth month of gestation. This is because meconium starts to form after three months of gestational age. As advantages of using mass spectrometry in obstetrics and gynecology, we can mention here the noninvasive character of the method and the fact that the results will be obtained even before the act of birth in some cases or immediately after the birth. This will allow a fast intervention, when necessary.
By using mass spectrometry, many diseases can be prevented, which could cause several problems for the child immediately or in the future. It is critical to find all of these as early as possible, especially in the case of high-risk pregnancies.
The high-risk pregnancies are defined as all cases which are affected by at least one of the above mentioned factors: -young maternal age (below 16 years old) -old maternal age (above 35 years old) -overweight or underweight -problems in previous pregnancies -bad health condition of the mother It is of great interest to have a method which can provide good results about fetal exposure to alcohol and drugs. Fetal alcohol spectrum disorder (FASD) is supposed to affect up to 1% of newborn babies and shows deficits at neurobehavioral level [11, 12] . Because of the population health, screening neonates who may be affected with fetal alcohol spectrum disorder is of great interest. The implementation of a universal screening program must be a priority in the future.
2.
The analysis of the biomarkers will bring important information about different fetal exposures during pregnancy. One very common biological marker is meconium, the first stools of the newborn child. Meconium is almost sterile, very viscous, with no odor. Unlike later feces, meconium contains different materials ingested during the intra uterus life, as amniotic fluid, intestinal epithelial cells, bile, water, mucus etc. Meconium begins to form at around the age of 12 weeks of gestation. It serves as a reservoir of feta chemical exposures (including alcohol and drugs) during last six months of pregnancy.
The diagnosis of fetal alcohol spectrum disorder (FASD) is difficult, because the mothers in many cases don't report the use of alcohol [11, 12] . This is a psychological limitation. If the mother used ethanol during gestation, the alcohol conjugates to fatty acids and will form fatty acid ethyl esters (FAEEs) via esterification reactions. The fatty acid ethyl esters in meconium have proved to be very good biomarkers of prenatal in utero alcohol exposure (PAE), since for the mother which never drinks during gestation, their values are expected to be zero [13, 14] . The fatty acid ethyl esters cannot cross the placenta, so as much are detected in meconium represent the fetal exposure to alcohol during the last six months of gestation [15] .
To show how mass spectrometry can be useful to determine the fetal exposure to alcohol, above we will show the results obtained in an universal neonatal screening study which was performed recently in GreyBruce region of Ontario, United States [11, 16, 17] . It gave a lot of information about fetal alcohol exposure and has determined the rate of fetal ethylic alcohol exposure in that region in the general population.
The mothers that agreed to take part in the mentioned study [11] were instructed to deposit their baby's meconium into the specimen bag. All the specimen bags containing the meconium were stored immediately until analysis, at a temperature of (-20°C), in an opaque diaper which reduced the degradation because of light. The samples are very sensitive temperature, and if they will not be stored at (-20°C) , the results will be affected. The duration of the study was one year [11] .
The collection of meconium was made anonymously, so all the procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration from 1975 regarding human experimentation.
The use of mass spectrometry to determine the prenatal alcohol exposure
The fatty acid ethyl esters were extracted using a method proposed by Pragst [18, 19] which include head space solid microextraction (HS-SPME) and gas chromatography / mass spectrometry. The deuterated standards of few fatty esters were added to be used as internal standards. [11, 16, 17] A standard curve was obtained using blank meconium and the four esters presented in Fig. 1 . These fatty esters (1-4) were used at different concentrations [11] .
The fiber was injected into a gas chromatograph connected with a mass spectrometer operated in electrospray ionization mode (ESI). The detection limits of the fatty acid ethyl esters were 15 ng g -1 for the compounds 1, 3 and 4, and 50 ng g -1 for the compound 2 (Fig. 1) .
The study of alcohol fetal exposure by using meconium unfortunately has several limitations. As was mentioned already, a limitation of the study [11] is multiple births (twins or triplets). Another limitation was that the fatty acid ethyl esters in meconium are only detected in the last six months of gestation. Additional limitations include delays of up to 5 days in the meconium expulsion in premature neonates.
The results of the study published in [11] showed a higher rate of fatty acid ethyl esters positive meconium among new born babies in a high-risk obstetric unit, compared with the general population (30% vs. 2.5%). Similar to the study of Gareri et al. [16] , for the general population studied in [11] the fatty acid ethyl esters with the highest concentration in the positive sample were ethyl oleate and ethyl linoleate [11, 16] . Elevation of ethyl oleate and ethyl linoleate was previously proposed as sensitive markers by themselves in the populations from United States and from South Africa [12, 13, 20] .
The ethyl palmitate has been reported also as the predominate sum of fatty acid ethyl esters in the positive samples [21] [22] [23] . The elevated levels of FAEEs in meconium have been associated with fetal alcohol spectrum disorder deficits (decreased executive function, poor neurodevelopment outcome, growth restriction) [24, 25] .
Concerning the stability of the samples, other studies [26] proved that FAEEs are sensitive to temperature, and also to light. Moore et al. previously showed that the specimens are very stable when stored in a freezer at (-20°C) [26] . In agreement with Moore, in the study published in [11] the samples were immediately placed at a temperature of (-20°C) to prevent degradation.
Affecting 1% of individuals, as mentioned before, fetal alcohol spectrum disorder (FASD) is the leading preventable cause of developmental disability in North America [27] . When compared with other neonatal diseases, the prevalence of FASD is much higher [18, 28] . The persons diagnosed with FASD, later in life showed a higher risk for many secondary disabilities [29] .
Prenatal alcohol exposure (PAE) may have dramatic consequences in exposed fetuses. Meconium levels of FAEEs highly correlate with prenatal alcohol exposure [12, 13, 30] and their relevance was showed and proved also in a recent study where increased levels of five FAEEs were significantly associated with poor mental and psychomotor development in the first two years of age [25] . Meconium analysis for fatty acid ethyl esters (FAEEs) is a validated method for identifying prenatal alcohol exposure. It was proved in [31] that a delay in the sample collection (for instance in case of premature births) can result in false-positive test results for FAEEs, because the samples could be contaminated with postnatal produced stool. This is the main disadvantage or limitation of the method for the premature neonates. So, it is very important to collect the meconium as early is possible for an accurate determination of FAEEs [11, 31] .
A new LC/MS method for quantifying FAEEs in meconium was also recently reported elsewhere [32] [33] [34] [35] . 
3.
The use of illicit drugs during pregnancy is a major problem in the present days. An average of 5 % of pregnant women, with the age ranging from 15 to 44 years, reported illicit drug use during pregnancy [36] . The use of drugs in this period will lead to serious obstetric complications (premature labor, abruption placenta, placenta insufficiency, placenta praevia, spontaneous abortion, preeclampsia, gestational diabetes etc) [37, 38] . In utero drug exposure will have a serious impact to the development of the child (decrease of body length, birth weight and head circumference, neurodevelopment complications, fetal distress and many others) [39] [40] [41] .
In the United States, the methadone (structure 5, Fig. 2 ) is the only drug approved for the treatment of opioid-dependent pregnant women. It is associated with decrease in illicit drug use [42] [43] [44] . Anyway, the pharmacotherapy with methadone is controversy because of the risk of neonatal abstinence syndrome (NAS) [45, 46] .
The interviewing techniques to find out if the mother use drugs during pregnancy are not the best, and because of several reasons (social reasons, legal consequences and law punishment) many pregnant women avoid the answer. Maternal and neonatal urine screening during pregnancy has traditionally been the primary analytical technique for detecting the use of drugs in pregnancy [47, 48] .
The procedure has many advantages [49]:
-easy collection -lack of sensitivity -low cost -accurate analytical techniques
The main disadvantage of urine testing is the short window of detection [50, 51] . It identifies the drug exposure just for few days before the act of birth. Meconium, the first neonatal fecal matter, could be an alternative, as for the determination of alcohol use. It offers the possibility of detection of in utero drug exposure from as early as the fourth month of gestation. The meconium has also other limitations as shown in the previous chapter of this review [52] [53] [54] .
Montgomery and co-workers [55] suggested that the umbilical cord is a better alternative to meconium and urine, for detecting fetal drug exposure. The umbilical cord is abundant and available at the time of birth. The research was later extended to GC/MS. This method confirmed positive results on many cases of pregnant women suspected of illicit drug consumption. Negative and positive values were higher than 98% and 70% respectively, for cannabinoids, methamphetamine (6), opiates, cocaine (7) and phencyclidine (8) (structures are presented in Fig. 3) [50, 56] . Winecker et al. described in their work [57] , a new GC/MS method for the determination of cocaine (7) in umbilical cord and in amniotic fluid. The detection is shorter in umbilical cord than in amniotic fluid. This method developed by Winecker et al. [57] could be also used for the determination of cocaine metabolites.
Quantification of several drugs in human umbilical cord by using a liquid chromatography/mass spectrometry method (LC/MS)
Moore and co-workers [58] reported also the determination of cocaine and benzoylecgonine (BE, 9 Fig. 4 ) in umbilical cord. Moreover, in the study published in [50] a LC/MS method for the quantification of several drugs (methadone, cocaine opiates, metabolites) in umbilical cord tissue is described. The molecular structures of few of these drugs are presented in the Figs. 4 and 5.
Mass spectrometric analyses were performed on an ion trap mass spectrometer with an electrospray ionization source (ESI). A tissue homogenizer was used for umbilical cord homogenization.
The mass spectra, as described in [50] , were recorded in the positive mode, at the temperature of 300°C. The MS analysis for all compounds was based on the MS2 fragment with the highest intensity. Another two fragments (MS2 or MS3) were monitored as well for each compound, except for EDDP (in the case of EDDP this was not possible, because only one MS3 fragment was available, and not two as for the other compounds) [50] .
As described in [50] in all cases the number of identification points was bigger than five, fulfilling the European Community acceptance criteria for this kind of determinations, of at least three identification points [59] . This is the first validated method for the determination in the same time of cocaine, methadone, EDDP, BE, 6AM, morphine and codeine in umbilical cord [50] . This type of analysis offers several advantages, as time and cost savings [50] .
The quantification of methadone (from women receiving this drug) makes possible a correlation between the concentrations of methadone in umbilical cord and the administered doses of it [50].
4.
17-hydroxyprogesterone caproate (17-OHPC, 14) is a synthetic steroid hormone, similar to medroxyprogesteron acetate (MPA, 15) and megestrol acetate. The chemical structures of 17-OHPC (14) and MPA (15) are presented in Fig. 6 . 17-OHPC is an ester derivative of 17-hydroxyprogesterone formed from caproic acid (hexanoic acid). A specific and very sensitive method for the determination of 17-OHPC in human plasma, with high performance liquid chromatography (HPLC) and mass spectrometry has been developed in the study published in [60] .
Preterm delivery is a major issue responsible for several complications in pregnancy, for many diseases after the act of birth and for the infant mortality [61, 62] . 17-hydroxyprogesterone caproate has recently been suggested to be beneficial in preventing preterm labor in women with a prior preterm birth [63] [64] [65] . The administration of the synthetic hormone 17-OHPC is intramuscularly and is used weekly. The amount of 17-hydroxyprogesterone caproate used is usually 250 mg. This treatment is efficient from weeks 16 to Development and validation of a LC/MS method for the determination of 17-hydroxyprogesterone caproate (17-OHPC) in human plasma using mass spectrometry 20 and then continued until 37 weeks in women with a history of prior preterm birth.
An analytical method was necessary to characterize the pharmacokinetics of 17-OHPC. The methods developed before for this kind of determinations were based mostly on immunoassay or HPLC [66, 67] . In [68], gas chromatography was used for the determination of 17-OHPC in plasma.
Unfortunately this method is time consuming. This issue was solved by using mass spectrometry with electrospray ionization in the positive ion mode, as described in [60] . For 17-OHPC analyses, electrospray ionization mode (ESI) gave a much better signal than the atmospheric pressure chemical ionization mode (APCI). The plasma standard samples to be analyzed were stored at −20°C [60] . The study described in [60] proved that it is possible to use liquid chromatography / mass spectrometry for the quantification of 17-OHPC in plasma. Under different conditions, a significant change in the 17-OHPC content was not observed. This proved the very high stability of 17-OHPC [60].
5.
The estriol-3-sulfate-16-glucuronide (16) is a synthetic estrogen, derivate from the female sexual hormone estriol (17) (Fig. 7) . To determinate the presence of this hormone during gestation in the pregnancy serum, mass spectrometry was also used.
A determination method for estriol-3-sulfate-16-glucuronide (E3-3S-16G) in pregnancy serum by liquid chromatography / electrospray ionization-tandem mass spectrometry (LC/MS/MS) has been developed in the work published in [69] . E3-3S-16G gave an intense deprotonated ion in the negative ion mode mass spectra.
The serum sample was diluted and heated before analysis. This procedure was followed by a solid phase extraction and the obtained sample was analyzed with liquid chromatography / tandem mass spectrometry (LC/MS/MS), as described in [69] . The used stock solution of E3-3S-16G was prepared in methanol (10 μg mL -1 ) [69] . The stock solution of E3-3S-16G in this case was prepared in methanol at 10 µg mL -1 and then subsequent dilutions were carried out [69] .
The developed method [69] was applied to serum samples obtained from pregnant women from the 6 th to 9 th month of gestational age. The estriol hormone (E3) during gestation is produced mostly in the placenta. In fact, most of E3 exists as conjugates. For example its major form in blood is the double conjugate estriol-3-sulfate-16-glucuronide (E3-3S-16G, Fig. 7) [70].
The steroid conjugates are polar compounds. It is well known that liquid chromatography / mass spectrometry (LC/MS) is a very good method to analyze polar structures. In the same time, this analytical method 
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16-glucuronide (E3-3S-16G) in pregnancy serum using LC/MS/MS
has many advantages (e.g. it is very specific and sensitive method, it allows the detection of very small amounts of compounds in different biological markers) [69] [70] [71] .
Conclusions
In this review, few examples of using mass spectrometry in obstetrics and gynecology are shown. The mass spectrometry could be used together with chromatography to analyze different biomarkers. One of the first application of mass spectrometry in obstetrics and gynecology is the work of E.C. Horning and M.G. Horning in the late 60's and early 70's [3,4] .
These applications of mass spectrometry in obstetrics and gynecology are based on the analysis of the biological markers available in pregnancy, as meconium, placenta, umbilical cord or pregnancy serum.
The alcohol consumption during pregnancy is an important reason for prematurity and for intrauterine growth retardation [34] . The preterm delivery is an important cause responsible for the infant mortality [61, 62] . Moreover, the mothers who used alcohol or drugs for long time showed a higher risk rates for gestational diabetes, hypertension and psychiatric problems [35] .
Also, a sensitive and in the same time a very selective liquid chromatography / tandem mass spectrometry assay procedure using solid phase extraction for the specific and quantitative analysis of 17-hydroxyprogesterone caproate in human plasma was developed and validated in the study published in [60] . The results published in [60] showed that the analysis requires only 400 microliters of plasma, which is a big advantage. The data obtained in the study described in [69] proved that a liquid chromatography / tandem mass spectrometry method has been developed for the determination of estriol-3-sulfate-16-glucuronide in the pregnancy serum, with good reproducibility. The mass spectrometry is very sensitive, fast and reproducible method. The studies mentioned in the present review are only few examples of using mass spectrometry in obstetrics and gynecology. All of them show the importance of mass spectrometry in this field. The described noninvasive techniques are of great interest for the future.
As it was shown, there are still many problems to be solved. These methods need to be developed and extended further. 
